Vice Provost and Dean of Research
Showing 1,741-1,760 of 2,495 Results
-
Kabir Peay
Senior Associate Dean for Education, Director of the Earth Systems Program, Professor of Biology, of Earth System Science and Senior Fellow at the Woods Institute for the Environment
Current Research and Scholarly InterestsOur lab studies the ecological processes that structure natural communities and the links between community structure and the cycling of nutrients and energy through ecosystems. We focus primarily on fungi, as these organisms are incredibly diverse and are the primary agents of carbon and nutrient cycling in terrestrial ecosystems. By working across multiple scales we hope to build a 'roots-to-biomes' understanding of plant-microbe symbiosis.
-
Donna Peehl, PhD
Professor (Research) of Urology, Emerita
Current Research and Scholarly InterestsMy research focuses on the molecular and cellular biology of the human prostate. Developing realistic experimental models is a major goal, and primary cultures of prostatic epithelial and stromal cells are my main model system. Our discoveries are relevant to prevention, detection, diagnosis and treatment of benign and malignant prostatic diseases.
-
Mark Pegram
Susy Yuan-Huey Hung Professor
Current Research and Scholarly InterestsMolecular mechanisms of targeted therapy resistance in breast and other cancers
-
Norbert Pelc
Boston Scientific Applied Biomedical Engineering Professor and Professor of Radiology, Emeritus
Current Research and Scholarly InterestsBroadly, Dr. Pelc is interested in the physics, engineering and mathematics of medical imaging, especially computed tomography, digital x-ray imaging, magnetic resonance imaging, and hybrid multimodality systems. His current research is concentrated in the development of computed tomography systems with higher image quality and dose efficiency, in the characterization of system performance, and in the development and validation of new clinical applications.
-
Gary Peltz
Professor of Anesthesiology, Perioperative and Pain Medicine (Department Research)
Current Research and Scholarly InterestsThe laboratory develops and uses state of the art genomic methods to identify genetic factors affecting disease susceptibility, and to translate these findings into new treatments. We have developed a more efficient method for performing mouse genetic analysis, which has been used to analyze the genetic basis for 16 different biomedical traits. We are developing novel methods, and have developed a novel experimental platform that replaces mouse liver with functioning human liver tissue.
-
Alex P Pentland
Center Fellow at the Stanford Institute for Human-Centered AI
BioAlex “Sandy” Pentland is HAI Center Fellow and faculty lead for digital society at Stanford HAI and Digital Economy Lab, He is Toshiba Professor at MIT, member of US National Academies, Advisor to Abu Dhabi Investment Authority Lab, and formerly advisory board member at UN Secretary General’s office, Google, ATT, Telefonica, and elsewhere. Spin-off companies and open source systems from his lab manage authentication of most digital transactions in the world, media for roughly 1B people in far east, and health resources for roughly 0.5B people in the indopacific. His current focus is on problems and opportunities in using AI to improve our social institutions.
-
Jon-Paul Pepper, MD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsFacial paralysis is a debilitating condition that affects thousands of people. Despite excellent surgical technique, we are currently limited by the regenerative capacity of the body. The mission of our research is to identify new treatments that improve current facial paralysis treatments. We do this by exploring the regenerative cues that the body uses to restore tissue after nerve injury, in particular through pathways of neurogenesis and nerve repair in small mammals.
-
Marco Perez
Associate Professor of Medicine (Cardiovascular Medicine)
BioDr. Marco Perez's research goal is to better understand the fundamental causes of cardiovascular disease through the study of genetics and epidemiology. His group studies the genetic variations and environmental exposures that are associated with conditions such as atrial fibrillation and heart failure. He has led the studies of atrial fibrillation in Women's Health Initiative, one of the largest nation-wide population-based cohorts. He is currently conducting a large study monitoring for silent or asymptomatic atrial fibrillation in women from the WHI randomized to exercise intervention, and was co-PI of the Apple Heart Study, a clinical trial that validated the ability of a smartwatch to detect atrial fibrillation. He is now PI of the Clinical Coordinating Center at Stanford for the REACT-AF which is a clinical trial to evaluate efficacy and safety of a "pill-in-the pocket" approach to anticoagulation for AF using a smartwatch. He is interested in understanding the paradox that atrial fibrillation is less common in African Americans and Hispanics, despite a greater burden of risk factors such as hypertension. As director of the Stanford Inherited Arrhythmia Clinic, he evaluates families with rare inherited arrhythmias associated with sudden death such as Long QT and Brugada Syndromes and explores their links with novel genes. He also studies the genetic causes of very early onset atrial fibrillation. He also studies how best to use the electrocardiogram and imaging modalities using Machine Learning techniques to identify patients at risk for cardiovascular disease. Dr. Perez receives funding from the NIH/NHLBI, Apple Inc., Janssen and the Colson Foundation.
-
VJ Periyakoil, Professor of Medicine
Professor of Medicine (Primary Care and Population Health)
Current Research and Scholarly InterestsMy lab is focused on longevity and healthy aging research.
-
Petra Persson
Associate Professor of Economics, Senior Fellow at the Stanford Institute for Economic Policy Research and Associate Professor, by courtesy, of Health Policy
BioPetra Persson is Associate Professor of Economics at Stanford University, where she also serves as the Nina C. Crocker Faculty Scholar in the School of Humanities and Sciences and holds a courtesy appointment as Associate Professor of Health Policy. She is a Faculty Research Associate at the National Bureau of Economic Research, a Senior Fellow at the Stanford Institute for Economic Policy Research, and a Research Affiliate at the Centre for Economic Policy Research.
Professor Persson earned her PhD in Economics from Columbia University in 2013, her MSc in Economics from Stockholm School of Economics in 2006, and her BA in Political Science and Mathematics from Stockholm University in 2005. Prior to joining the Stanford faculty, she was a Postdoctoral Fellow at the Stanford Institute for Economic Policy Research (2013-2014) and a Dissertation Fellow at the Harvard Kennedy School Women and Public Policy Program (2012-2013).
Persson's research lies at the intersection of family economics, health economics, and public finance, spanning topics including health disparities, maternal and child well-being, family structure and behavior, fertility policy, and social insurance design. She is the recipient of the National Science Foundation CAREER Award and has published articles in leading peer-reviewed journals, including the American Economic Review, Journal of Political Economy, American Economic Review: Insights, American Economic Journal: Applied Economics, American Economic Journal: Economic Policy, and British Medical Journal. -
Claudia Katharina Petritsch
Associate Professor (Research) of Neurosurgery
Senior Research Scientist, Adult NeurologyCurrent Research and Scholarly InterestsThe Petritsch lab broadly investigates underlying causes for the intra-tumoral heterogeneity and immune suppression in brain tumors from a neuro-developmental perspective. Defective cell fate decisions fuel the intra-humoral heterogeneity and plasticity in human brain tumors and may contribute to immune suppression. We use patient-derived models as avatars to study how brain cells control the fate of their progeny, whereby we unravel novel points of vulnerabilities in brain tumor cells.
